{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:39:58Z","timestamp":1761489598415},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/mp.2015.21","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T08:55:01Z","timestamp":1426582501000},"page":"237-242","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multi-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcomes in longitudinal studies of bipolar disorder"],"prefix":"10.1038","volume":"21","author":[{"given":"C L","family":"Bowden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Tohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"BFmp201521_CR1","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/sim.4780091106","volume":"9","author":"PP Glasziou","year":"1990","unstructured":"Glasziou PP, Simes RJ, Gelber RD . Quality adjusted survival analysis. Stat Med 1990; 9: 1259\u20131276.","journal-title":"Stat Med"},{"key":"BFmp201521_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00031305.1995.10476135","volume":"49","author":"RD Gelber","year":"1995","unstructured":"Gelber RD, Cole BF, Gelber S, Aron G . Comparing treatments using quality-adjusted survival: the Q-Twist method. Am Stat 1995; 49: 161\u2013169.","journal-title":"Am Stat"},{"key":"BFmp201521_CR3","first-page":"40","volume":"155","author":"DR Cox","year":"1992","unstructured":"Cox DR, Fitzpatrick R, Fletcher AE, Gore SM, Spiegelhalter DJ, Jones DR et al. Quality-of-life assessment: can we keep it simple? JSTOR 1992; 155: 40.","journal-title":"JSTOR"},{"key":"BFmp201521_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1001\/archpsyc.1990.01810240026005","volume":"47","author":"M Tohen","year":"1990","unstructured":"Tohen M, Waternaux CM, Tsuang MT . Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47: 1106\u20131111.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201521_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","volume":"59","author":"LL Judd","year":"2002","unstructured":"Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530\u2013537.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201521_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","volume":"64","author":"JR Calabrese","year":"2003","unstructured":"Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64: 1013\u20131024.","journal-title":"J Clin Psychiatry"},{"key":"BFmp201521_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","volume":"60","author":"CL Bowden","year":"2003","unstructured":"Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392\u2013400.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201521_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4088\/JCP.v65n0321","volume":"65","author":"GM Goodwin","year":"2004","unstructured":"Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432\u2013441.","journal-title":"J Clin Psychiatry"},{"key":"BFmp201521_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","volume":"11","author":"M Tohen","year":"2009","unstructured":"Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN et al. The international society for bipolar disorders (ISBD) task force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009; 11: 453\u2013473.","journal-title":"Bipolar Disord"},{"key":"BFmp201521_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFmp201521_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","volume":"35","author":"J Endicott","year":"1978","unstructured":"Endicott J, Spitzer RL . A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837\u2013844.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201521_CR12","first-page":"5","volume":"2","author":"S Datta","year":"2004","unstructured":"Datta S . Estimating the mean life time using right censored data. Stat Methodol 2004; 2: 5.","journal-title":"Stat Methodol"},{"key":"BFmp201521_CR13","first-page":"1","volume":"66","author":"M Zhong","year":"2009","unstructured":"Zhong M, Hess KR . Mean survival time from right censored data. Collect Biostat Res Arch 2009; 66: 1\u20135.","journal-title":"Collect Biostat Res Arch"},{"key":"BFmp201521_CR14","unstructured":"Efron B . The two sample problem with censored data. Berkeley Symp Math Stat Prob 1967; 4."},{"key":"BFmp201521_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"W Cochran","year":"1954","unstructured":"Cochran W . The combination of estimates from different experiments. Biometrics 1954; 10: 101\u2013129.","journal-title":"Biometrics"},{"key":"BFmp201521_CR16","unstructured":"Lanza ST, DJ J, Huang L, Xu S, Collins LM, . Software Proc LCA & Proc LTA users' guide (Version 1.2.7). 2011 University Park: The Methodology Center: Pennsylvania, USA."},{"key":"BFmp201521_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/1740774509347399","volume":"6","author":"AA Nierenberg","year":"2009","unstructured":"Nierenberg AA, Sylvia LG, Leon AC, Reilly-Harrington NA, Ketter TA, Calabrese JR et al. Lithium treatment \u2014 moderate dose use study (LiTMUS) for bipolar disorder: rationale and design. Clin Trials 2009; 6: 637\u2013648.","journal-title":"Clin Trials"},{"key":"BFmp201521_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1399-5618.2004.00104.x","volume":"6","author":"C Baethge","year":"2004","unstructured":"Baethge C, Schlattmann P . A survival analysis for recurrent events in psychiatric research. Bipolar Disord 2004; 6: 7.","journal-title":"Bipolar Disord"},{"key":"BFmp201521_CR19","volume-title":"Hierarchical Linear Models: Applications and Data Analysis Methods","author":"SW Raudenbush","year":"2002","unstructured":"Raudenbush SW, Bryk AS . Hierarchical Linear Models: Applications and Data Analysis Methods, (2nd ed.) SAGE Publications: University of Chicago, 2002."},{"key":"BFmp201521_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1399-5618.2011.00924.x","volume":"13","author":"P Roussos","year":"2011","unstructured":"Roussos P, Giakoumaki SG, Georgakopoulos A, Robakis NK, Bitsios P . The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord 2011; 13: 250\u2013259.","journal-title":"Bipolar Disord"},{"key":"BFmp201521_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/ng.209","volume":"40","author":"MA Ferreira","year":"2008","unstructured":"Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40: 1056\u20131058.","journal-title":"Nat Genet"},{"key":"BFmp201521_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/sj.mp.4002151","volume":"13","author":"P Sklar","year":"2008","unstructured":"Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008; 13: 558\u2013569.","journal-title":"Mol Psychiatry"},{"key":"BFmp201521_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","volume":"166","author":"T Suppes","year":"2009","unstructured":"Suppes T, Vieta E, Liu S, Brecher M, Paulsson B . Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry 2009; 166: 476\u2013488.","journal-title":"Am J Psychiatry"},{"key":"BFmp201521_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/mpr.262","volume":"17","author":"JM Gonzalez","year":"2008","unstructured":"Gonzalez JM, Bowden CL, Katz MM, Thompson P, Singh V, Prihoda TJ et al. Development of the bipolar inventory of symptoms scale: concurrent validity, discriminant validity and retest reliability. Int J Methods Psychiatr Res 2008; 17: 198\u2013209.","journal-title":"Int J Methods Psychiatr Res"},{"key":"BFmp201521_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.psychres.2009.04.017","volume":"175","author":"PM Thompson","year":"2010","unstructured":"Thompson PM, Gonzalez JM, Singh V, Schoolfield JD, Katz MM, Bowden CL et al. Principal domains of behavioral psychopathology identified by the bipolar inventory of signs and symptoms scale (BISS). Psychiatry Res 2010; 175: 221\u2013226.","journal-title":"Psychiatry Res"},{"key":"BFmp201521_CR26","doi-asserted-by":"publisher","first-page":"B40","DOI":"10.1016\/j.clinthera.2011.11.020","volume":"33","author":"S Srivastava","year":"2011","unstructured":"Srivastava S, Ketter TA . Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects. Clinical Ther 2011; 33: B40\u2013B48.","journal-title":"Clinical Ther"},{"key":"BFmp201521_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0447.2012.01894.x","volume":"127","author":"V Singh","year":"2013","unstructured":"Singh V, Bowden CL, Gonzalez JM, Thompson P, Prihoda TJ, Katz MM et al. Discriminating primary clinical states in bipolar disorder with a comprehensive symptom scale. Acta Psychiatr Scand 2013; 127: 145\u2013152.","journal-title":"Acta Psychiatr Scand"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp201521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp201521","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp201521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T21:59:25Z","timestamp":1717797565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp201521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFmp201521"],"URL":"https:\/\/doi.org\/10.1038\/mp.2015.21","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]},"assertion":[{"value":"21 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CLB has received research support from Elan and participated in a Data Monitoring Board for Takeda. JM declares no conflict of interest. MT was a full time employee at Lilly (1997\u20132008). He has received honoraria from, or consulted for, Abbott, AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Lilly, Johnson & Johnson, Otsuka, Merck, Sunovion, Forest, Geodon Richter Plc, Roche, Elan, Alkermes, Lundbeck, Teva, Pamlab, Wyeth and Wiley Publishing and his spouse was a full time employee at Lilly (1998\u20132013).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}